E-LIB Suche - Ergebnisse für: Flowers, Christopher R

1

Defining primary refractory large B-cell lymphoma:

Bock, Allison M. ; Mwangi, Raphael ; Wang, Yucai...
Blood Advances. 8 (2024) 13 - p. 3402-3415 , 2024

2

Population pharmacokinetics and exposure–response analyses ..:

Deng, Rong ; Gibiansky, Leonid ; Lu, Tong...
CPT: Pharmacometrics & Systems Pharmacology. 13 (2024) 6 - p. 1055-1066 , 2024

Link: https://doi.org/10.1002/..

3

Cardiovascular events reported in patients with B-cell mali..:

Moslehi, Javid J. ; Furman, Richard R. ; Tam, Constantine S....
Blood Advances. 8 (2024) 10 - p. 2478-2490 , 2024

Link: https://doi.org/10.1182/..

4

Safety, efficacy and determinants of response of allogeneic..:

Marin, David ; Li, Ye ; Basar, Rafet...
Nature Medicine. 30 (2024) 3 - p. 772-784 , 2024

Link: https://doi.org/10.1038/..

5

Clinical outcomes of patients with newly diagnosed large B-..:

Jiang, Jun Y. ; Nze, Chijioke ; Guffey, Danielle...
Blood Neoplasia. 1 (2024) 3 - p. 100020 , 2024

Link: https://doi.org/10.1016/..

6

Polatuzumab vedotin, venetoclax, and an anti‐CD20 monoclona..:

Yuen, Sam ; Phillips, Tycel J. ; Bannerji, Rajat...
American Journal of Hematology. 99 (2024) 7 - p. 1281-1289 , 2024

Link: https://doi.org/10.1002/..

7

CASi: A framework for cross-timepoint analysis of single-ce..:

Wang, Yizhuo ; Flowers, Christopher R. ; Wang, Michael..
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

8

Thrombosis risk prediction in lymphoma patients: A multi‐in..:

Ma, Shengling ; La, Jennifer ; Swinnerton, Kaitlin N....
American Journal of Hematology. 99 (2024) 7 - p. 1230-1239 , 2024

Link: https://doi.org/10.1002/..

9

Evaluating Lab-Based Eligibility Criteria by Race/Ethnicity..:

Khurana, Arushi ; Mwangi, Raphael ; Nastoupil, Loretta J....
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

10

Impact of Demographics and Neighborhood Socioeconomic Varia..:

Nze, Chijioke ; Andersen, Clark ; Ayers, Amy...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

11

Clinical Outcomes in Patients with Lymphoma at a Safety - N..:

Nze, Chijioke ; Jiang, Jun Y ; Guffey, Danielle...
International Journal of Cancer Care and Delivery. , 2024

Link: https://doi.org/10.53876..

12

Response-adapted ultra-low-dose 4 Gy radiation as definitiv..:

Gunther, Jillian R ; Xu, Jie ; Bhutani, Manoop S...
The Lancet Haematology. 11 (2024) 7 - p. e521-e529 , 2024

Link: https://doi.org/10.1016/..

13

Matching-adjusted indirect comparison from the Lymphoma Epi..:

Maurer, Matthew J. ; Casulo, Carla ; Larson, Melissa C....
Haematologica. , 2023

Link: https://doi.org/10.3324/..

14

Integrative analysis of clinicopathological features define..:

Vose, Julie M. ; Fu, Kai ; Wang, Lu...
Journal of Hematology & Oncology. 16 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

15

Polatuzumab vedotin plus bendamustine and rituximab or obin..:

Flowers, Christopher R. ; Matasar, Matthew J. ; Herrera, Alex F....
Haematologica. , 2023

Link: https://doi.org/10.3324/..